Practical issues across the lifetime of heart failure

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 2, 2011, Pages 151-153

  Lumb, Joanna ^a  

^a Medical Writer   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; IVABRADINE; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CONFERENCE PAPER; DEFIBRILLATOR; DRUG DOSE TITRATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEALTH CARE PERSONNEL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OVERLOAD; KIDNEY FAILURE; LOW DRUG DOSE; MEDICAL HISTORY; PATIENT REFERRAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 79952144514     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.193     Document Type: Conference Paper

References (6)

1. Swedberg K, Komajda M, Bohm M et al.; on behalf of the SHIFT investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376, 875-885 (2010).
2. Zannad F, McMurray JJV, Krum H et al.; the EMPHASIS-HF study group. Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med. DOI: 10.1056/NEJMoa1009492 (2010) (Epub ahead of print).
3. Jacobson AF, Senior R, Cerqueira MD et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J. Am. Coll. Cardiol. 55, 2212-2221 (2010).
4. Boogers, MJ, Borleffs CJ, Hennemann MM et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients J. Am. Coll. Cardiol. 55, 2769-2777 (2010).
5. Damman K, Van Veldhuisen DJ, Navis G et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96, 1297-1302 (2010).
6. Inglis SC, Clark RA, McAlister FA et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database System. Rev. 8, CD007228 (2010).